Universitatsklinikum Augsburg

Augsburg 86156

2 studies enrolling now · 3 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, CLL, Chronic Lymphocytic Leukemia, Metastatic Non-Small Cell Lung Cancer, Relapsed/Refractory Follicular Non-Hodgkin Lymphoma

Studies at this site

• A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors — Recruiting now
• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma — Completed